F19.96
Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F19.96 refers to a condition characterized by the use of unspecified psychoactive substances leading to a persistent amnestic disorder. This condition involves ongoing memory impairments caused by substance use, which can significantly impact an individual's daily functioning and quality of life. Recognizing and understanding this diagnosis can help in seeking appropriate support and management for affected individuals.
Causes & Symptoms
Clinical Causes: Use of various psychoactive substances such as alcohol, illicit drugs, or prescription medications that affect brain function. Prolonged or heavy consumption of psychoactive substances leading to neurological changes. Pre-existing mental health conditions that increase the likelihood of substance use and related memory issues. Environmental and social factors influencing substance use behaviors.
Key Symptoms: Memory loss or gaps in recalling recent events or personal information. Difficulty learning new information or recalling past experiences. Confusion or disorientation related to memory functions. Changes in cognition such as impaired concentration or attention. Possible behavioral alterations due to memory deficits, including confusion or apathy.
Diagnostic & Treatment
Diagnosis Path: Diagnosing this condition typically involves a comprehensive clinical assessment, including detailed medical history, psychological evaluation, and cognitive testing. Healthcare providers may use neuropsychological tests to evaluate memory function and identify the extent of cognitive impairment. Laboratory tests and brain imaging might be used to rule out other causes of memory loss and to assess the effects of substance use on the brain.
Treatment Protocols: Management strategies focus on addressing the underlying substance use disorder and supporting cognitive recovery. Approaches may include: - **Substance cessation** through counseling, therapy, or medication-assisted treatment. - **Cognitive rehabilitation** programs to improve memory and cognitive skills. - **Psychotherapy** to address behavioral and mental health issues related to substance use. - **Support groups** and community resources to provide ongoing assistance. - **Monitoring and follow-up** to assess progress and adjust treatment plans as needed.
Clinical Advice & FAQs
Billing Guidance
Is F19.96 a billable ICD-10 code?
Yes, F19.96 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F19.96?
Clinical documentation must specify the nature of Other psychoactive substance use, unspecified with psychoactive substance-induced persisting amnestic disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
